Ambu AS (WBO:AMBU) Beta: N/A (As of Jul. 03, 2026)


WBO:AMBU Ambu AS WBO:AMBU
63 GF Score
Price €8.90
GF Value €17.16
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-03), Ambu AS's Beta is Not available.

Ambu AS  (WBO:AMBU) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Ambu AS Beta Related Terms

Ambu AS Beta Historical Data

* Premium members only.

The historical data trend for Ambu AS's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Beta Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:AMBU
63GF Score
Ambu AS WBO:AMBU
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Ambu AS (WBO:AMBU) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of €8.90 is trading 48.1% below its estimated GF Value™ of €17.16. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for WBO:AMBU:

  • Beta: N/A
  • GF Value™: €17.16 vs. price of €8.90 (48.1% below fair value)
  • GF Score™: 63/100

No single metric tells the full story. See the WBO:AMBU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
63GF Score

Get the complete analysis for WBO:AMBU

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.90
Price
€17.16
GF Value